APIXABANA 2,5 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1832604870031 -
GGREM
576722080098506 -
Código de barras
7891058003258
O que a fonte publica
- Detentor do registro
- SANOFI MEDLEY FARMACÊUTICA LTDA.
- Princípios ativos
- APIXABANA
- Embalagem
- 2,5 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "APIXABANA 2,5 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60",
"holder": "SANOFI MEDLEY FARMACÊUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891058003258"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "576722080098506",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "10.588.595/0010-92",
"priceRegime": "Regulado",
"productName": "APIXABANA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "2,5 MG COM REV CT BL AL PLAS PVC/PVDC TRANS X 60",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "169.14",
"icms-12": "192.20",
"icms-17": "203.78",
"icms-18": "206.27",
"icms-19": "208.81",
"icms-20": "211.43",
"icms-21": "214.10",
"icms-22": "216.85",
"icms-23": "219.66",
"icms-17.5": "205.02",
"icms-19.5": "210.11",
"icms-20.5": "212.75",
"icms-22.5": "218.25",
"icms-12-alc": "189.90",
"icms-17-alc": "201.34",
"icms-18-alc": "203.79",
"icms-19-alc": "206.31",
"icms-20-alc": "208.89",
"icms-21-alc": "211.53",
"icms-22-alc": "214.24",
"icms-23-alc": "217.03",
"withoutTaxes": "167.11",
"icms-17.5-alc": "202.56",
"icms-19.5-alc": "207.59",
"icms-20.5-alc": "210.20",
"icms-22.5-alc": "215.63"
},
"pisCofinsList": "Positiva",
"substanceText": "APIXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "233.14",
"icms-12": "264.93",
"icms-17": "280.89",
"icms-18": "284.32",
"icms-19": "287.82",
"icms-20": "291.43",
"icms-21": "295.11",
"icms-22": "298.91",
"icms-23": "302.78",
"icms-17.5": "282.60",
"icms-19.5": "289.61",
"icms-20.5": "293.25",
"icms-22.5": "300.83",
"icms-12-alc": "262.53",
"icms-17-alc": "278.34",
"icms-18-alc": "281.73",
"icms-19-alc": "285.21",
"icms-20-alc": "288.78",
"icms-21-alc": "292.43",
"icms-22-alc": "296.17",
"icms-23-alc": "300.03",
"withoutTaxes": "231.02",
"icms-17.5-alc": "280.03",
"icms-19.5-alc": "286.98",
"icms-20.5-alc": "290.59",
"icms-22.5-alc": "298.10"
},
"invalidBarcodes": [],
"activeSubstances": [
"APIXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1832604870031",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:576722080098506"